These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 2181378)
1. Cytoplasmic pH and anchorage-independent growth induced by v-Ki-ras, v-src or polyoma middle T. Schwartz MA; Rupp EE; Frangioni JV; Lechene CP Oncogene; 1990 Jan; 5(1):55-8. PubMed ID: 2181378 [TBL] [Abstract][Full Text] [Related]
2. Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha-transforming growth factors in ras-transformed mouse mammary epithelial cells. Salomon DS; Perroteau I; Kidwell WR; Tam J; Derynck R J Cell Physiol; 1987 Mar; 130(3):397-409. PubMed ID: 3494020 [TBL] [Abstract][Full Text] [Related]
3. Transformation-restoring factor: a low molecular weight secreted factor required for anchorage-independent growth of oncogene-resistant mutant cell lines. Yang JJ; Kang JS; Krauss RS Oncogene; 1995 Apr; 10(7):1291-9. PubMed ID: 7731679 [TBL] [Abstract][Full Text] [Related]
4. Effect of low extracellular Ca2+ on growth, spreading area, cytoplasmic Ca2+ concentration, and intracellular pH in normal and transformed human fibroblasts. Yoshida T; Takahashi Y; Takashima S J Cell Physiol; 1993 Feb; 154(2):301-9. PubMed ID: 8425911 [TBL] [Abstract][Full Text] [Related]
5. Tumor rejection antigens on BALB3T3 cells transformed by activated oncogenes. Torigoe T; Sato N; Takashima T; Cho JM; Tsuboi N; Qi WM; Hara I; Wada Y; Takahashi N; Kikuchi K J Immunol; 1991 Nov; 147(9):3251-8. PubMed ID: 1919013 [TBL] [Abstract][Full Text] [Related]
6. Suppression of malignant growth potentials of v-Src-transformed human gallbladder epithelial cells by adenovirus-mediated dominant negative H-Ras. Tokumitsu Y; Nakano S; Ueno H; Niho Y J Cell Physiol; 2000 May; 183(2):221-7. PubMed ID: 10737897 [TBL] [Abstract][Full Text] [Related]
7. Anchorage-independent growth of v-myc-transformed Balb/c 3T3 cells is promoted by platelet-derived growth factor or co-transformation by other oncogenes. Vennström B; Bravo R Oncogene; 1987; 1(3):271-6. PubMed ID: 3330775 [TBL] [Abstract][Full Text] [Related]
8. Dissociation of ras oncogene-induced gene expression and anchorage-independent growth in a series of somatic cell mutants. Feinleib JL; Krauss RS Mol Carcinog; 1996 Jul; 16(3):139-48. PubMed ID: 8688149 [TBL] [Abstract][Full Text] [Related]
9. SCH 51344 inhibits ras transformation by a novel mechanism. Kumar CC; Prorock-Rogers C; Kelly J; Dong Z; Lin JJ; Armstrong L; Kung HF; Weber MJ; Afonso A Cancer Res; 1995 Nov; 55(21):5106-17. PubMed ID: 7585559 [TBL] [Abstract][Full Text] [Related]
10. Down-regulation of NF-kappaB activity and NF-kappaB p65 subunit expression by ras and polyoma middle T oncogenes in human colonic Caco-2 cells. Cadoret A; Bertrand F; Baron-Delage S; Lévy P; Courtois G; Gespach C; Capeau J; Cherqui G Oncogene; 1997 Apr; 14(13):1589-600. PubMed ID: 9129150 [TBL] [Abstract][Full Text] [Related]
11. Restored expression of transforming growth factor beta type II receptor in k-ras-transformed thyroid cells, TGF beta-resistant, reverts their malignant phenotype. Coppa A; Mincione G; Lazzereschi D; Ranieri A; Turco A; Lucignano B; Scarpa S; Ragano-Caracciolo M; Colletta G J Cell Physiol; 1997 Aug; 172(2):200-8. PubMed ID: 9258341 [TBL] [Abstract][Full Text] [Related]
12. Production of and responsiveness to transforming growth factor-beta in normal and oncogene-transformed human mammary epithelial cells. Valverius EM; Walker-Jones D; Bates SE; Stampfer MR; Clark R; McCormick F; Dickson RB; Lippman ME Cancer Res; 1989 Nov; 49(22):6269-74. PubMed ID: 2553252 [TBL] [Abstract][Full Text] [Related]
13. Differential growth sensitivity to 4-cis-hydroxy-L-proline of transformed rodent cell lines. Ciardiello F; Sanfilippo B; Yanagihara K; Kim N; Tortora G; Bassin RH; Kidwell WR; Salomon DS Cancer Res; 1988 May; 48(9):2483-91. PubMed ID: 2833347 [TBL] [Abstract][Full Text] [Related]
14. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors. Spandidos DA Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595 [TBL] [Abstract][Full Text] [Related]
15. Effect of cell spreading on cytoplasmic pH in normal and transformed fibroblasts. Schwartz MA; Both G; Lechene C Proc Natl Acad Sci U S A; 1989 Jun; 86(12):4525-9. PubMed ID: 2734302 [TBL] [Abstract][Full Text] [Related]
16. v-erbA cooperates with bFGF in neuroretina cell transformation. Garrido C; Li RP; Samarut J; Gospodarowicz D; Saule S Virology; 1993 Feb; 192(2):578-86. PubMed ID: 7678474 [TBL] [Abstract][Full Text] [Related]
17. Role of chromosome loss in ras/myc-induced Syrian hamster tumors. Oshimura M; Koi M; Ozawa N; Sugawara O; Lamb PW; Barrett JC Cancer Res; 1988 Mar; 48(6):1623-32. PubMed ID: 2449958 [TBL] [Abstract][Full Text] [Related]
18. A nonkaryophilic T antigen of SV40 can either immortalize or transform rodent cells, and cooperates better with cytoplasmic than with nuclear oncoproteins. Fischer-Fantuzzi L; Vesco C Oncogene Res; 1987 Aug; 1(3):229-42. PubMed ID: 2835734 [TBL] [Abstract][Full Text] [Related]
19. The use of in vitro assays for neoplastic transformation and tumor promotion. Rosa S; Bignami M Ann Ist Super Sanita; 1989; 25(4):545-8. PubMed ID: 2631620 [TBL] [Abstract][Full Text] [Related]
20. K-Ras promotes growth transformation and invasion of immortalized human pancreatic cells by Raf and phosphatidylinositol 3-kinase signaling. Campbell PM; Groehler AL; Lee KM; Ouellette MM; Khazak V; Der CJ Cancer Res; 2007 Mar; 67(5):2098-106. PubMed ID: 17332339 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]